Which supervision and treatment in case of exposure to Parvovirus B19 during pregnancy?;Quelles surveillance et thérapeutique appliquer en cas de contage avec le Parvovirus B19 en cours de grossesse ?

Gynecologie Obstetrique et Fertilite

Volumn 36, Issue 2, 2008, Pages 204-211

  Brochot, C ^a   Debever, P ^a   Subtil, D ^a   Puech, F ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Fetal anaemia; Fetus; Hydrops fetalis; In utero transfusion; Parvovirus B19; Pregnancy; Prenatal diagnosis; Prevention

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANEMIA; ARTICLE; ASCITES; ECHOGRAPHY; ENVIRONMENTAL EXPOSURE; ERYTHEMA INFECTIOSUM; FETUS DEATH; FETUS HYDROPS; FETUS OUTCOME; FETUS WASTAGE; GESTATIONAL AGE; HUMAN; INFORMATION RETRIEVAL; INTRAUTERINE INFECTION; MATERNAL SERUM; NERVE CELL DIFFERENTIATION; OUTCOME ASSESSMENT; PARVOVIRUS; PERICARDIAL EFFUSION; PREGNANCY COMPLICATION; SPONTANEOUS ABORTION; SURVIVAL; VERTICAL TRANSMISSION; VIROLOGY;

EID: 43049097171     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2007.08.028     Document Type: Article

References (49)

1. M.J. Anderson Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 8338 1983 1378
2. B.J. Cohen M.M. Buckley The prevalence of antibody to human parvovirus B19 in England and Wales J Med Microbiol 25 1988 151 153
3. A.K. Valeur-Jensen Risk factors for parvovirus B19 infection in pregnancy Jama 281 1999 1099 1105
4. R. Levy Infection by parvovirus B 19 during pregnancy: a review Obstet Gynecol Surv 52 1997 254 259
5. N.S. Young K.E. Brown Parvovirus B19 N Engl J Med 350 2004 586 597
6. K.E. Brown S.M. Anderson N.S. Young Erythrocyte P antigen: cellular receptor for B19 parvovirus Science 262 1993 114 117
7. J.J. Lefrere Safety of blood products and B19 parvovirus Transfus Clin Biol 13 2006 235 241
8. K. Broliden T. Tolfvenstam O. Norbeck Clinical aspects of parvovirus B19 infection J Intern Med 260 2006 285 304
9. L.J. Anderson Role of parvovirus B19 in human disease Pediatr Infect Dis J 6 1987 711 718
10. M. Enders A. Weidner G. Enders Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany Epidemiol Infect 2006 1 7
11. I.P. Jensen An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors Bjog 107 2000 637 643
12. N.J. Gay Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Commun Dis Rep CDR Rev 4 1994 R104 R107
13. W.R. Ballou Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1 J Infect Dis 187 2003 675 678
14. H. Chisaka Clinical manifestations and outcomes of parvovirus B19 infection during pregnancy in Japan Tohoku J Exp Med 209 2006 277 283
15. S.M. Gillespie Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum Jama 263 1990 2061 2065
16. T. Chorba The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease) J Infect Dis 154 1986 383 393
17. J.H. Harger Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms Obstet Gynecol 91 1998 413 420
18. J.F. Rodis Human parvovirus infection in pregnancy Obstet Gynecol 72 1988 733 738
19. M. Enders Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases Prenat Diagn 24 2004 513 518
20. D.M. Reid Human parvovirus-associated arthritis: a clinical and laboratory description Lancet 1 1985 422 425
21. P. Seve Systemic manifestations of Parvovirus B19 infections Rev Med Interne 25 10 2004 740 751
22. I.P. Jensen B.F. Vestergaard Assessment of the specificity of a commercial human parvovirus B19 IgM assay Clin Diagn Virol 7 3 1997 133 137
23. C. Malm E. Fridell K. Jansson Heart failure after parvovirus B19 infection Lancet 341 1993 1408 1409
24. T.R. de Haan Parvovirus B19 infection in pregnancy studied by maternal viral load and immune responses Fetal Diagn Ther 22 2007 55 62
25. E. Miller Immediate and long term outcome of human parvovirus B19 infection in pregnancy Br J Obstet Gynaecol 105 1998 174 178
26. T. Marton W.L. Martin M.J. Whittle Hydrops fetalis and neonatal death from human parvovirus B19: an unusual complication Prenat Diagn 25 2005 543 545
27. E. Gratacos The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome J Infect Dis 171 1995 1360 1363
28. H.T. Nagel Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection Obstet Gynecol 109 2007 42 47
29. T. Brown Intrauterine parvovirus infection associated with hydrops fetalis Lancet 8410 1984 1033 1034
30. C.S. von Kaisenberg W. Jonat Fetal parvovirus B19 infection Ultrasound Obstet Gynecol 18 2001 280 288
31. Z. Ergaz A. Ornoy Parvovirus B19 in pregnancy Reprod Toxicol 21 2006 421 435
32. Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease. BMJ, 1990;300:1166–70.
33. E.P. de Jong Parvovirus B19 infection in pregnancy J Clin Virol 36 2006 1 7
34. G. Mari Middle cerebral artery peak systolic velocity: is it the standard of care for the diagnosis of fetal anemia? J Ultrasound Med 24 2005 697 702
35. G. Mari Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after 2 previous intrauterine transfusions Am J Obstet Gynecol 193 2005 1117 1120
36. M. Dobec Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy Gynecol Obstet Invest 63 2007 53 54
37. M. Enders Human parvovirus B19 infection during pregnancy - value of modern molecular and serological diagnostics J Clin Virol 35 2006 400 406
38. D. Dieck Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum Prenat Diagn 19 1999 1119 1123
39. D.H. Saltzman Sonographic evaluation of hydrops fetalis Obstet Gynecol 74 1989 106 111
40. K.J. Moise Jr. Intrauterine transfusion with red cells and platelets West J Med 159 1993 318 324
41. G.R. Markenson M.K. Yancey Parvovirus B19 infections in pregnancy Semin Perinatol 22 1998 309 317
42. J.F. Rodis Parvovirus infection Clin Obstet Gynecol 42 1999 107 120 quiz 174–5
43. M.T. Peters K.H. Nicolaides Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection Obstet Gynecol 75 1990 501 504
44. J.F. Rodis Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians Am J Obstet Gynecol 179 1998 985 988
45. H. Matsuda Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin J Perinat Med 33 2005 561 563
46. R. Nanal P. Kyle P.W. Soothill A classification of pregnancy losses after invasive prenatal diagnostic procedures: an approach to allow comparison of units with a different case mix Prenat Diagn 23 2003 488 492
47. K.E. Brown Congenital anaemia after transplacental B19 parvovirus infection Lancet 343 8902 1994 895 896
48. J.F. Rodis Long-term outcome of children following maternal human parvovirus B19 infection Obstet Gynecol 91 1998 125 128
49. J. Dembinski Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops Bjog 109 2002 1232 1234